Oncothyreon Inc., which is developing drugs for the treatment of cancer, said that it has received commitments from investors to purchase stock and warrants valued at $15 million. The Seattle company also named Diana Hausman -- formerly of ZymoGentics -- as vice president of clinical development.
Seattle's Walk Score gets a positive review from Opposing Views, with Kaid Benfield writing that "it's great fun, and highly useful in generating a rough approximation of how "smart" a location is." The review also mentions how the site integrates with real estate sites such as Zillow.com and Estately.
Speaking of real estate, DocuSign today introduced enhanced features for its electronic signature which are specifically geared toward real estate professionals. The service --which starts at $19.95 per month -- is designed to eliminate the printing and faxing of real estate documents when a transaction is nearing completion.
The University of Washington Bothell MBA Program is launching a Leadership MBA program this fall at its Eastside Leadership Center in Bellevue. Information is available here. Demand for the LMBA program has been high, despite the recession, but there are still slots open, says Sandeep Krishnamurthy, director of the UW Bothell Business Administration Program. UW Bothell also offers a Technology Management MBA Program at its Bothell campus.
Getty Images today introduced a new set of products designed for those seeking images to display on Web sites and mobile devices. Andy Saunders, vice president of creative imagery at the Seattle company, said that images will allow customers to get "high quality imagery quickly, easily and at the appropriate price points." Images in the collection range from $5 to $49, which compares to some of the free images offered in the creative commons section of Flickr.
The Life Sciences Discovery Fund -- which was established by Washington state to support cutting-edge life science research -- today announced grants totaling $300,000 for two University of Washington researchers. The UW's Kenneth Schenkman and his team received $150,000 "to test a new instrument for the diagnosis and monitoring of shock" while the UW's Philip Fleckman received $150,000 "to test the ability of a percutaneous catheter to resist infection."
Boston venture capitalist Jeff Bussgang explains why it's tough to say "no" all of the time.
READ MORE and COMMENT
No comments:
Post a Comment